Postoperative Analgesia in a Rat Model of Bone Cancer
A researcher is using a rat model of bone cancer pain. Male Sprague-Dawley rats (n=40, 250-300g) undergo intratibial injection of MRMT-1 carcinoma cells into the right tibia. The protocol includes a sham group (n=10) receiving heat-killed cells. Postoperative analgesia is provided with buprenorphine (0.01 mg/kg SC q8h) for 48 hours. On day 7 post-injection, rats are assessed for mechanical allodynia using von Frey filaments. The researcher notes that some rats show severe lameness and weight loss (>20% of body weight) by day 10. The IACUC-approved protocol allows for euthanasia if weight loss exceeds 20% or if the rat shows signs of distress (e.g., hunched posture, reluctance to move). The facility veterinarian recommends adding meloxicam (1 mg/kg SC q24h) for 3 days starting day 7. However, the researcher is concerned that meloxicam (a COX-2 inhibitor) might interfere with tumor growth and pain measurements.
1. Evaluate whether the addition of meloxicam at day 7 is appropriate from both animal welfare and scientific perspectives. Consider the mechanism of action, potential confounders, and the IACUC protocol. What would you recommend?
Read the worked answer
From a welfare perspective, the rats showing severe lameness and weight loss are in distress, and the protocol mandates euthanasia for >20% weight loss. Meloxicam could provide analgesia and reduce inflammation, potentially improving welfare. However, from a scientific perspective, meloxicam is a COX-2 inhibitor and may affect tumor microenvironment, angiogenesis, and pain pathways. It could confound pain measurements (von Frey) and tumor growth data. The protocol likely does not include meloxicam, so adding it would require an amendment. Recommendation: First, ensure humane endpoints are strictly followed-euthanize any rat with >20% weight loss or severe distress immediately. For the remaining rats, consider a short course of meloxicam (3 days) as rescue analgesia, but document it as a potential confounder. Alternatively, use a different analgesic with less COX-2 activity (e.g., buprenorphine) or adjust dose. Since the study aims to assess bone cancer pain, minimizing confounders is crucial; however, welfare takes precedence. A compromise: administer meloxicam only to rats showing distress, and exclude them from pain analysis, or use a control group receiving meloxicam to assess effect. Ultimately, the IACUC must approve any change; the veterinarian's recommendation should be followed unless scientifically justified otherwise.
2. Calculate the number of rats that would need to be euthanized by day 10 if the weight loss criterion is applied, assuming a normal distribution of weight loss with mean 15% and standard deviation 5% at day 10, and the threshold is 20%. Use the 68-95-99.7 rule.
Read the worked answer
Using the 68-95-99.7 rule for normal distribution: mean = 15%, SD = 5%. Threshold = 20% is 1 SD above mean (20-15=5, which is 1 SD). Approximately 16% of the distribution lies above 1 SD (since 68% within 1 SD, 32% outside, half above = 16%). Therefore, about 16% of 40 rats = 6.4 rats, so approximately 6-7 rats would exceed 20% weight loss and require euthanasia by day 10. This is a significant proportion, highlighting the need for better analgesia or earlier intervention.